Integrated DNA Technologies Purchases VH Bio's Oligo Business

NEW YORK (GenomeWeb News) – Oligonucleotide synthesis company Integrated DNA Technologies announced today that it has purchased VH Bio's oligonucleotide business.

Under the agreement, IDT will serve VH Bio's oligonucleotide customers from IDT's European synthesis facility, which opened in Leuven, Belgium, this past September. As such, IDT plans to provide current VH Bio customers with a broader product range of quality-controlled oligonucleotides that are available for next-day delivery.
Financial terms of the agreement were not disclosed.

IDT and VH Bio, which is based in Gateshead, UK, also announced that they plan to work together to expand IDT's oligonucleotide business in the UK. VH Bio will continue distributing its other products, including those for immunologists and molecular biologists.